Receptor Usage in Malaria and Its Impact on Disease Outcome
Author Information
Author(s): Lucy B. Ochola, Bethsheba R. Siddondo, Harold Ocholla, Siana Nkya, Eva N. Kimani, Thomas N. Williams, Johnstone O. Makale, Anne Liljander, Britta C. Urban, Pete C. Bull, Tadge Szestak, Kevin Marsh, Alister G. Craig
Primary Institution: KEMRI/Wellcome Trust Research Programme, Centre for Geographic Medicine Research, Kilifi, Kenya
Hypothesis
The study investigates the association between specific receptor usage in Plasmodium falciparum cytoadherence and the clinical outcomes of malaria.
Conclusion
Increased binding to CD36 is linked to uncomplicated malaria, while higher ICAM-1 adhesion is associated with cerebral malaria cases.
Supporting Evidence
- 80% of clinical isolates bound to both CD36 and ICAM-1.
- Children with severe malaria showed reduced adhesion to CD36 compared to those with uncomplicated malaria.
- Binding to ICAM-1 was significantly higher for cerebral malaria isolates than for uncomplicated malaria cases.
Takeaway
This study found that how malaria parasites stick to blood vessels can affect how sick a person gets; some stick more than others.
Methodology
The study analyzed cytoadherence patterns of patient isolates to CD36 and ICAM-1 using static and flow adhesion assays.
Potential Biases
Bias may arise from only analyzing isolates with high parasitaemia, which could affect the generalizability of the findings.
Limitations
The study may have excluded some severe malaria cases due to a parasitaemia cutoff, potentially biasing results.
Participant Demographics
Children with malaria from Kilifi District Hospital, Kenya, aged between 1 to 5 years.
Statistical Information
P-Value
p=0.006
Confidence Interval
95% CI, 829.0–1525.3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website